164 related articles for article (PubMed ID: 38405104)
1. Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration.
Tanaka A; Hata M; Tsuchikawa M; Ueda-Arakawa NU; Tamura H; Miyata M; Takahashi A; Kido A; Muraoka Y; Miyake M; Ooto S; Tsujikawa A
Clin Ophthalmol; 2024; 18():507-516. PubMed ID: 38405104
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration.
Matsumoto H; Hiroe T; Morimoto M; Mimura K; Ito A; Akiyama H
Jpn J Ophthalmol; 2018 Mar; 62(2):144-150. PubMed ID: 29411171
[TBL] [Abstract][Full Text] [Related]
3. Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration.
Elfandi S; Ooto S; Miyata M; Ueda-Arakawa N; Subhi Y; Yamashiro K; Tamura H; Oishi A; Hata M; Yoshimura N; Tsujikawa A
Clin Ophthalmol; 2021; 15():1539-1549. PubMed ID: 33883872
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy.
Yoon J; Yoon W; Na SK; Lee J; Kim CG; Kim JW; Cho HJ
Sci Rep; 2021 Jun; 11(1):12052. PubMed ID: 34103603
[TBL] [Abstract][Full Text] [Related]
5. Differences in Central and Peripheral Choroidal Thickness among the Subtypes of Age-Related Macular Degeneration in an Asian Population.
Fukuda Y; Notomi S; Shiose S; Kano K; Hashimoto S; Fujiwara K; Akiyama M; Ishikawa K; Hisatomi T; Sonoda KH
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629406
[TBL] [Abstract][Full Text] [Related]
6. Anti-VEGF Treatment Strategies for 3 Subtypes of Neovascular Age-Related Macular Degeneration in a Clinical Setting: A Multicenter Cohort Study in Japan.
Yoneda K; Takeuchi M; Yasukawa T; Terasaki H; Yamamoto Y; Jujo T; Wakuta M; Matsubara H; Mitamura Y; Kato A; Kondo M; Kimura K; Takagi H; Gomi F; Sakamoto T;
Ophthalmol Retina; 2023 Oct; 7(10):869-878. PubMed ID: 37295608
[TBL] [Abstract][Full Text] [Related]
7. Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration.
Kuranami A; Maruko R; Maruko I; Hasegawa T; Iida T
Sci Rep; 2023 May; 13(1):7379. PubMed ID: 37149627
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors after aflibercept therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy.
Ogasawara M; Koizumi H; Yamamoto A; Itagaki K; Saito M; Maruko I; Okada AA; Iida T; Sekiryu T
Jpn J Ophthalmol; 2018 Sep; 62(5):584-591. PubMed ID: 29974277
[TBL] [Abstract][Full Text] [Related]
9. Comparison of functional and morphologic changes between brolucizumab and faricimab in neovascular age-related macular degeneration.
Maruyama-Inoue M; Yanagi Y; Inoue T; Kadonosono K
Graefes Arch Clin Exp Ophthalmol; 2024 Feb; 262(2):589-599. PubMed ID: 37750953
[TBL] [Abstract][Full Text] [Related]
10. Age-Related Maculopathy Susceptibility 2 and Complement Factor H Polymorphism and Intraocular Complement Activation in Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Ishida Y; Machida T; Sekine H; Sekiryu T
Ophthalmol Sci; 2022 Jun; 2(2):100167. PubMed ID: 36249678
[TBL] [Abstract][Full Text] [Related]
11. Early responses to intravitreal ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Matsumiya W; Honda S; Bessho H; Kusuhara S; Tsukahara Y; Negi A
J Ophthalmol; 2011; 2011():742020. PubMed ID: 21772985
[TBL] [Abstract][Full Text] [Related]
12. Improvements of Retinal Sensitivity after Intravitreal Injection of Aflibercept in Eyes with Neovascular Age-Related Macular Degeneration with or without Polypoidal Choroidal Vasculopathy.
Nizawa T; Kitahashi M; Baba T; Iwase T; Kubota-Taniai M; Hattori Y; Shiko Y; Kawasaki Y; Iwase T; Sato T; Ogawa S; Sugawara T; Yamamoto S
Ophthalmologica; 2021; 244(4):347-360. PubMed ID: 34015785
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of intravitreal ranibizumab in exudative age-related macular degeneration (AMD): comparison between typical neovascular AMD and polypoidal choroidal vasculopathy over a 1 year follow-up.
Matsumiya W; Honda S; Kusuhara S; Tsukahara Y; Negi A
BMC Ophthalmol; 2013 Apr; 13():10. PubMed ID: 23557322
[TBL] [Abstract][Full Text] [Related]
14. Three-month outcomes of faricimab loading therapy for wet age-related macular degeneration in Japan.
Mukai R; Kataoka K; Tanaka K; Miyara Y; Maruko I; Nakayama M; Watanabe Y; Yamamoto A; Wakatsuki Y; Onoe H; Wakugawa S; Terao N; Hasegawa T; Hashiya N; Kawai M; Maruko R; Itagaki K; Honjo J; Okada AA; Mori R; Koizumi H; Iida T; Sekiryu T
Sci Rep; 2023 May; 13(1):8747. PubMed ID: 37253802
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy.
Yamashiro K; Yanagi Y; Koizumi H; Matsumoto H; Cheung CMG; Gomi F; Iida T; Tsujikawa A
J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956229
[TBL] [Abstract][Full Text] [Related]
16. Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration.
Kishi M; Miki A; Kamimura A; Okuda M; Matsumiya W; Imai H; Kusuhara S; Nakamura M
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568546
[TBL] [Abstract][Full Text] [Related]
17. Short-term outcomes of intravitreal faricimab for treatment-naïve neovascular age-related macular degeneration.
Matsumoto H; Hoshino J; Nakamura K; Nagashima T; Akiyama H
Graefes Arch Clin Exp Ophthalmol; 2023 Oct; 261(10):2945-2952. PubMed ID: 37195339
[TBL] [Abstract][Full Text] [Related]
18. Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.
Kato Y; Oguchi Y; Omori T; Shintake H; Tomita R; Kasai A; Ogasawara M; Sugano Y; Itagaki K; Ojima A; Machida T; Sekine H; Sekiryu T
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):39. PubMed ID: 33252634
[TBL] [Abstract][Full Text] [Related]
19. Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy.
Siedlecki J; Klaas JE; Keidel LF; Asani B; Luft N; Priglinger SG; Schworm B
Ophthalmol Retina; 2022 Sep; 6(9):807-813. PubMed ID: 35398547
[TBL] [Abstract][Full Text] [Related]
20. Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.
Kataoka K; Itagaki K; Hashiya N; Wakugawa S; Tanaka K; Nakayama M; Yamamoto A; Mukai R; Honjyo J; Maruko I; Kawai M; Miyara Y; Terao N; Wakatsuki Y; Onoe H; Mori R; Koizumi H; Sekiryu T; Iida T; Okada AA;
Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):43-51. PubMed ID: 37668741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
